Blog

Unlocking Bioprocess Secrets with Smart Equations!
π Dive into bioprocessing! Researchers revealed how equations enhance understanding of *Bacillus thuringiensis* production dynamics. π§ͺππ‘

Unlocking Innovation: Rethink Bioreactor Designs Today!
**Excerpt:** π± Biopharmaceutical companies can explore innovative bioreactor designs! π‘ Emphasizing growth conditions is key. π Single-use options offer sustainability! π Adapt for efficiency! π

UK Invests Big in Advanced Therapy Manufacturing!
The U.K. is bullish on advanced therapy manufacturing! πͺπ° Β£520 million investment fosters innovation and retains gene therapies. ππ

Biosensors Revolutionized: Faster Data Better Insights!
Discover how new Raman spectroscopy advances are revolutionizing biosensors! π Faster, cheaper analysis with accurate predictions. ππ§ͺπβ¨

Why Batch Data Fails in Continuous Cultivation
π± Continuous processing outshines batch methods, but transitioning Bacillus licheniformis is tricky. Fed-batch data alone won't cut it! π¬βοΈ

Why Expertise Beats Innovation in Biopharma Contracts
π Innovative tech in biopharma excites! But remember, expertise and flexibility are key to winning contracts. π§ͺπ‘ππ₯

Canada’s C3i Center Gets EMA Nod for Cell Therapy!
π Exciting news! C3i Center in Montreal gains EMA approval for cell therapy manufacturing in Europe, enhancing patient access to innovative treatments! π¬π¨π¦

Revolutionizing Filtration: Boosting Bioprocessing Efficiency!
**Excerpt:** Discover how advancements in tangential flow filtration are reducing product losses π§ and maximizing output π for bioprocessing efficiency! ππ¬

Revolutionary Molecule Mimics bFGF for Cell Cultures!
**Excerpt:** π± Exciting news! Guanylhydrazone-based molecules mimic bFGF, enhancing cell culture applications. Cost-effective, stable, and scalable! π‘π Innovation Biotech

β¬50 Million Boost for GLP-1 Production in France!
π Axplora invests β¬50M in France! ποΈ Boosting GLP-1 manufacturing for diabetes and obesity therapies. π Next-gen production by 2026! π





